Skip to main content
Log in

Educational no. 2: flow cytometry

  • educational
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

Flow cytometry (FC) plays an important role in the diagnosis and classification of hematological disorders and can analyze a wide range of diagnostic samples. It is used in both diagnostic and follow-up testing, and is increasingly important in the detection of very small residual disease populations, i. e., minimal residual disease (MRD). Modern flow cytometers have the capability to analyze several thousands of cells per second and to identify different cell populations by evaluating the expression of specific antigens (markers) along with light scatter properties of the cells. FC can precisely differentiate between B‑ and T‑cell malignancies, between mature and precursor tumors, and among the latter, determine the myeloid or lymphatic lineage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gorczyca W. Flow Cytometry in neoplastic hematology: morphologic-Immunophenotypic correlation. 3rd ed. Boca Raton: CRC Press; 2017.

    Book  Google Scholar 

  2. Leach M, Drummond M, Doig A. Practical flow cytometry in haematology diagnosis. Hoboken: Wiley-Blackwell; 2013.

    Book  Google Scholar 

  3. Brown M, Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem. 2000;46:1221–9.

    PubMed  CAS  Google Scholar 

  4. Givan AL. Principles of flow cytometry: an overview. Methods Cell Biol. 2001;63:19–50.

    Article  PubMed  CAS  Google Scholar 

  5. Leach M, Drummond M, Doig A, McKay P, Jackson B, Bain BJ. Practical flow Cytometry in Haematology : 100 worked examples. Hoboken: Wiley-Blackwell; 2015.

    Book  Google Scholar 

  6. Gaipa G, Basso G, Biondi A, Campana D. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom. 2013;84(6):359–69.

    Article  PubMed  CAS  Google Scholar 

  7. Wood BL. Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry. Cytometry B Clin Cytom. 2016;90:47–53.

    Article  PubMed  Google Scholar 

  8. Theunissen P, Mejstrikova E, Sedek L, van der Slujjs-Gelling AJ, Gaipa G, Bartels M, et al. Standardized flow cytometry for highly sensitive MRD measurements in B‑cell acute lymphoblastic leukemia. Blood. 2017;129(3):347–57.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Keeney M, Hedley BD, Chin-Yee ICH. Flow cytometry—Recognizing unusual populations in leukemia and lymphoma diagnosis. Int J Lab Hematol. 2017;39(Suppl 1):86–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katrin Hefler-Frischmuth M.D..

Ethics declarations

Conflict of interest

K. Hefler-Frischmuth declares that she has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hefler-Frischmuth, K. Educational no. 2: flow cytometry. memo 11, 168–171 (2018). https://doi.org/10.1007/s12254-018-0418-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-018-0418-9

Keywords

Navigation